Bio-Path (NASDAQ:BPTH) Now Covered by StockNews.com
Investment analysts at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the stock. Separately, Roth Mkm restated a “buy” rating and set a $20.00 target price on shares of Bio-Path in a report on Monday, July […]
17 Oct 08:22 · The Markets Daily